Works matching IS 00099104 AND DT 2023 AND VI 214 AND IP 2

Results: 9

Leucine-rich repeat kinase 2 promotes the development of experimental severe acute pancreatitis.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 182, doi. 10.1093/cei/uxad106
By:
- Otsuka, Yasuo;
- Hara, Akane;
- Minaga, Kosuke;
- Sekai, Ikue;
- Kurimoto, Masayuki;
- Masuta, Yasuhiro;
- Takada, Ryutaro;
- Yoshikawa, Tomoe;
- Kamata, Ken;
- Kudo, Masatoshi;
- Watanabe, Tomohiro
Publication type:
Article
Increased thromboinflammatory load in hereditary angioedema.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 170, doi. 10.1093/cei/uxad091
By:
- Gramstad, Olav Rogde;
- Schjalm, Camilla;
- Mollnes, Tom Eirik;
- Nielsen, Erik Waage
Publication type:
Article
The CXCL12-CXCR4-NLRP3 axis promotes Schwann cell pyroptosis and sciatic nerve demyelination in rats.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 219, doi. 10.1093/cei/uxad081
By:
- Li, Wei;
- Liang, Jie;
- Li, Shaohua;
- Jiang, Suli;
- Song, Meiying;
- Xu, Shuo;
- Wang, Luoyang;
- Meng, Haining;
- Zhai, Dongchang;
- Tang, Lei;
- Yang, Yanyan;
- Zhang, Bei
Publication type:
Article
Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 209, doi. 10.1093/cei/uxad088
By:
- Kamegai, Naoki;
- Kim, Hangsoo;
- Suzuki, Yasuhiro;
- Fukui, Sosuke;
- Kojima, Hiroshi;
- Maruyama, Shoichi;
- Morgan, B Paul;
- Zelek, Wioleta Milena;
- Mizuno, Masashi
Publication type:
Article
Alpha-ketoglutarate supplementation reduces inflammation and thrombosis in type 2 diabetes by suppressing leukocyte and platelet activation.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 197, doi. 10.1093/cei/uxad086
By:
- Agarwal, Sakshi;
- Ghosh, Riya;
- Verma, Garima;
- Khadgawat, Rajesh;
- Guchhait, Prasenjit
Publication type:
Article
Toxicity spectrum and risk factors for chemo-immunotherapy in locally advanced or metastatic lung cancer.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 162, doi. 10.1093/cei/uxad105
By:
- Li, Jinjin;
- Shi, Wenhao;
- Xiong, Jin;
- Huang, Yusheng;
- He, Yi;
- Zhou, Yan;
- Yang, Zhenzhou;
- Peng, Yuan
Publication type:
Article
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 154, doi. 10.1093/cei/uxad108
By:
- O'Reilly, Steven
Publication type:
Article
MAIT cells in bacterial infectious diseases: heroes, villains, or both?
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 144, doi. 10.1093/cei/uxad102
By:
- Wu, Sihong;
- Yang, Xi;
- Lou, Yongliang;
- Xiao, Xingxing
Publication type:
Article
Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.
Published in:
Clinical & Experimental Immunology, 2023, v. 214, n. 2, p. 131, doi. 10.1093/cei/uxad083
By:
- Christen, Urs;
- Pouzol, Laetitia;
- Tunis, Mélanie;
- Sassi, Anna;
- Tondello, Camilla;
- Bayer, Monika;
- Hintermann, Edith;
- Strasser, Daniel S;
- Schuldes, Sabrina;
- Mentzel, Ulrich;
- Martinic, Marianne M
Publication type:
Article